Results 31 to 40 of about 175,797 (297)

Chromosomal imbalances detected in primary bone tumors by comparative genomic hybridization and interphase fluorescence in situ hybridization

open access: yesGenetics and Molecular Biology, 2003
We applied a combination of comparative genomic hybridization (CGH) and fluorescence in situ hybridization (FISH), to characterize the genetic aberrations in three osteosarcomas (OS) and one Ewing's sarcoma. CGH identified recurrent chromosomal losses at
Marcelo Razera Baruffi   +4 more
doaj   +1 more source

Comparative genomic hybridization identifies virulence differences in Streptococcus suis. [PDF]

open access: yesPLoS ONE, 2014
Streptococcus suis is an important zoonotic pathogen. However, identification of virulent S. suis strains is complicated because of the high diversity of the species. Here we evaluated the genetic difference among S.
Han Zheng   +8 more
doaj   +1 more source

Comparative genomics in chicken and Pekin duck using FISH mapping and microarray analysis [PDF]

open access: yes, 2009
Background: The availability of the complete chicken (Gallus gallus) genome sequence as well as a large number of chicken probes for fluorescent in-situ hybridization (FISH) and microarray resources facilitate comparative genomic studies between chicken ...
Skinner, B.   +19 more
core   +6 more sources

CAISMOV24, a new human low-grade serous ovarian carcinoma cell line

open access: yesBMC Cancer, 2017
Background The spontaneous immortalization of primary malignant cells is frequently assigned to their genetic instability during in vitro culturing. In this study, the new epithelial ovarian cancer cell line CAISMOV24 was described and compared with its ...
Rodrigo Fernandes da Silva   +8 more
doaj   +1 more source

Identification of genomic alterations in pancreatic cancer using array-based comparative genomic hybridization. [PDF]

open access: yesPLoS ONE, 2014
BACKGROUND: Genomic aberration is a common feature of human cancers and also is one of the basic mechanisms that lead to overexpression of oncogenes and underexpression of tumor suppressor genes.
Jian-Wei Liang   +11 more
doaj   +1 more source

Combined subtractive cDNA cloning and array CGH: an efficient approach for identification of overexpressed genes in DNA amplicons [PDF]

open access: yes, 2004
Background: Activation of proto-oncogenes by DNA amplification is an important mechanism in the development and maintenance of cancer cells. Until recently, identification of the targeted genes relied on labour intensive and time consuming positional ...
De Preter, Katleen   +8 more
core   +2 more sources

Genomic profiling of oral squamous cell carcinoma by array-based comparative genomic hybridization. [PDF]

open access: yesPLoS ONE, 2013
We designed a study to investigate genetic relationships between primary tumors of oral squamous cell carcinoma (OSCC) and their lymph node metastases, and to identify genomic copy number aberrations (CNAs) related to lymph node metastasis.
Shunichi Yoshioka   +9 more
doaj   +1 more source

Genomic Profiling by Array Comparative Genomic Hybridization Reveals Novel DNA Copy Number Changes in Breast Phyllodes Tumours

open access: yesCellular Oncology, 2009
Breast phyllodes tumour (PT) is a rare fibroepithelial tumour. The genetic alterations contributing to its tumorigenesis are largely unknown. To identify genomic regions involved in pathogenesis and progression of PTs we obtained genome-wide copy number ...
Arno Kuijper   +6 more
doaj   +1 more source

Array comparative genomic hybridization with cyanin cis-platinum-labeled DNAs

open access: yesBioTechniques, 2004
Fluorescent cis-platinum compounds that react with the N7 atom of guanine are useful for labeling nucleic acids in fluorescence hybridization applications.
Anton K. Raap   +8 more
doaj   +1 more source

Integrative analyses identify modulators of response to neoadjuvant aromatase inhibitors in patients with early breast cancer [PDF]

open access: yes, 2015
Introduction Aromatase inhibitors (AIs) are a vital component of estrogen receptor positive (ER+) breast cancer treatment. De novo and acquired resistance, however, is common.
A Mackay   +65 more
core   +3 more sources

Home - About - Disclaimer - Privacy